Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity

Recruiting Observational Study
Androgen Insensitivity Syndrome Metabolic Parameters in AIS, CAIS, PAIS and MAIS Tumor Formation in AIS, CAIS, PAIS and MAIS Sexual Function AIS, CAIS, PAIS and MAIS
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
8 – 99
Sex
Any
Study type
Observational
Participants needed
650 (estimated)
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NIH
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background: Androgen effects in humans are usually (but not always) mediated by the androgen receptor which is coded for by the androgen receptor gene (AR gene). Androgen Insensitivity Syndrome (AIS) is a rare condition in which the body cannot sense the male hormones in the blood or tissue. Both women and men can be affected by AIS. Researchers want to learn more about the health of people with …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: Inclusion Criteria for AIS Subjects In order to be eligible to participate in this study, an individual must meet all the following criteria: 1. Individuals ages 8-99 years old with known androgen insensitivity based on pathologic androgen receptor gene mutation or based on …
Contacts

Veronica Gomez-Lobo, M.D.

(301) 435-7567

veronica.gomez-lobo@nih.gov

CONTACT